City Research Online

Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis

Husain, S., Allotey, J., Drymoussi, Z. , Wilks, M., Fernandez-Felix, B. M., Whiley, A., Dodds, J., Thangaratinam, S., McCourt, C. ORCID: 0000-0003-4765-5795, Prosdocimi, E. M., Wade, W. G., de Tejada, B. M., Zamora, J., Khan, K. & Millar, M. (2019). Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis. BJOG: An International Journal of Obstetrics and Gynaecology, 127(2), pp. 275-284. doi: 10.1111/1471-0528.15675

Abstract

OBJECTIVE: To determine the effects on the vaginal microbiota of an oral probiotic preparation administered from early pregnancy.

DESIGN: Randomised, double blind, placebo-controlled trial.

SETTING: Four maternity units in the UK.

POPULATION: Women aged 16 years or older recruited at 9-14 weeks' gestation.

METHODS: Participants were randomly allocated to receive oral capsules of probiotic containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 each at 2.5 × 109 colony-forming units (CFUs) or placebo once daily from recruitment until the end of pregnancy.

MAIN OUTCOME MEASURE: Rates of bacterial vaginosis (BV, defined as Nugent score ≥7) at 18-20 weeks' gestation compared by logistic regression adjusted for possible confounders.

RESULTS: The primary analysis included 78% (238/304) of participants who initially consented (probiotic group 123, placebo group 115). Of these participants, 95% (227/238) reported an intake of 93% or more of the required number of capsules. The rates of BV did not differ between groups at 18-20 weeks' gestation (15% (19/123) in the probiotic group vs. 9% (10/115) in the placebo group, adjusted odds ratio 1.82, 95% confidence interval 0.64-5.19). There were also no differences between the groups in the proportion of women colonised with the probiotic strains, Escherichia coli, Group B streptococci or other vaginal microbiota. There were no differences in the alpha diversity or composition of the bacterial communities between or within the probiotic and placebo groups at 9-14 and 18-20 weeks' gestation.

CONCLUSIONS: Oral probiotics taken from early pregnancy did not modify the vaginal microbiota.

TWEETABLE ABSTRACT: The oral probiotic preparation used in this study does not prevent BV in pregnant women.

Publication Type: Article
Additional Information: © 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecologypublished by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes
Publisher Keywords: Bacterial vaginosis, Lactobacillus reuteri, Lactobacillus rhamnosus, probiotic
Subjects: R Medicine
R Medicine > RG Gynecology and obstetrics
Departments: School of Health & Psychological Sciences > Midwifery & Radiography
SWORD Depositor:
[thumbnail of BJOG effect of oral probiotics on vaginal microbiota April19.pdf]
Preview
Text - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (609kB) | Preview

Export

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Downloads

Downloads per month over past year

View more statistics

Actions (login required)

Admin Login Admin Login